← Leaderboards
Geoffrey Raymond Oxnard
Dana-Farber Cancer Inst
$230,333
Attributed
$230,333
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$230,333 · 1
By mechanism
R21$230,333 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Eliezer M Van Allen$14,227,870
- Nathanael Schiander Gray$36,761,550
- Jennifer W Mack$13,071,700
- Rani E George$9,003,170
- Bruce E. Johnson$13,594,149
Others in their field
Other Emerging Leaders on “Advanced Malignant Neoplasm”
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,493,986
- Leonard Freedmand · Leidos Biomedical Research, Inc.$79,963,641
- Lynn Briscoe · Leidos Biomedical Research, Inc.$47,097,978
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
Advanced Malignant NeoplasmAnaplastic Lymphoma KinaseBiopsyBloodCancer Drug ResistanceCancer PatientCell Free DnaCellular AssayCohortCollaborationsCollectionConsentCrizotinibDiagnosisDrug ResistanceEarly TreatmentEffectivenessEnrollmentEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEvaluationFda ApprovedFollow-UpAcquired Drug Resistance